-
A Narrative Review of Lung Cancer Cytology in the Times of Coronavirus
Cytopathology plays a key role in the diagnosis and management of lung cancer. In what ways has the current pandemic impacted the handling and processing of these samples?
February 04, 2021
-
Treatments for Combined Small Cell Lung Cancer Patients
Which treatment strategies should be considered for this rare subtype of small cell lung cancer?
January 04, 2021
-
Recent Trends in Use of Adjuvant Chemotherapy in Elderly Stage II-III Non-Small Cell Lung Cancer
A new study examined recent trends in the patterns of use of adjuvant chemotherapy among elderly patients with lung cancer. What have we learned?
December 04, 2020
-
Uniportal Video-Assisted Thoracic Surgery for the Treatment of Lung Cancer
Should this procedure have a role in the treatment of lung cancer? A new consensus statement provides guidance and recommendations.
November 05, 2020
-
Integrating Clinical and Biological Prognostic Biomarkers in Patients With Advanced NSCLC Treated With Immunotherapy
What can these potential biomarkers tell us about the prognosis of immunotherapy-treated non-small cell lung cancer?
October 05, 2020
-
Role of Chest Radiographs in Early Lung Cancer Detection
Low-dose CT is traditionally used in the screening of patients at risk for lung cancer, but it has its limitations. Might chest radiography provide a viable alternative?
September 04, 2020
-
Feasibility and Safety of PD-1/L1 Inhibitors for Non-Small Cell Lung Cancer in Front-Line Treatment
Are PD-1/L1 inhibitors a safe and effective option for the front line treatment of patients with advanced non-small cell lung cancer?
August 07, 2020
-
Challenges and Countermeasures of Thoracic Oncology in the Epidemic of COVID-19
The COVID-19 epidemic has posed unique challenges to the diagnosis and treatment of cancer patients. Find out how the field of thoracic oncology is impacted.
July 08, 2020
-
Frontiers of ctDNA, Targeted Therapies, and Immunotherapy in Non-Small-Cell Lung Cancer
From ctDNA detection to immunotherapy and targeted therapies -- learn about the latest frontiers in non-small-cell lung cancer.
June 08, 2020
-
Endocrine Adverse Events Related to Immune-Oncology Agents
Learn more about the endocrine-related adverse events associated with the use of immune-oncology agents and how these toxicities should be managed.
May 08, 2020
-
Toxicity of Tumor Immune Checkpoint Inhibitors
Are you aware of the potential adverse events associated with immune checkpoint inhibitors? Find out how to identify and manage these toxic effects.
March 03, 2020
-
Society for Translational Medicine Consensus on Postoperative Management of EGFR-Mutant Lung Cancer (2019 Edition)
Consensus-based recommendations from the Society for Translational Medicine addresses the management of EGFR-mutated lung cancer.
February 03, 2020
-
Is Lowering the PD-L1 Threshold for First-Line Pembrolizumab Monotherapy a Good Idea?
What is the best treatment option for patients with advanced NSCLC and PD-L1 of 1-49% on tumor cells?
January 02, 2020
-
Current Perspectives on Statins as Potential Anti-Cancer Therapeutics
Which molecular mechanisms may drive the anticancer effects of statins?
December 03, 2019
-
Influence and Mechanism of Lung Cavitation Development on Antiangiogenic Therapy
Is development of lung cavitation following apatinib therapy for lung cancer associated with better outcomes?
November 06, 2019
-
Treatment Modes for EGFR Mutations in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Medical oncologists and radiation oncologists often disagree about management of brain metastases associated with EGFR+ NSCLC. These authors think "interdisciplinary collaboration" is needed.
October 22, 2019
-
Prognostic Role of Pretreatment Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy
Is an elevated neutrophil-to-lymphocyte ratio prior to receiving chemotherapy, immunotherapy, or targeted therapy associated with inferior survival in patients with NSCLC ?
September 27, 2019
-
Molecular Testing Strategies in Non-Small Cell Lung Cancer
These 'real world' tactics for molecular testing in patients with a new diagnosis of advanced NSCLC will help clinicians determine optimal first-line targeted therapy.
August 29, 2019
-
TNM Stages Inversely Correlate With The Age at Diagnosis in ALK-Positive Lung Cancer
Younger adults are more likely to be diagnosed with T3/4 stage ALK-positive lung cancer than older adults.
July 29, 2019
-
Lung Cancer Screening and Shared Decision Making in Cancer Survivors
Little is known about the effectiveness of lung cancer screening in cancer survivors, a group with very diverse characteristics. How should clinicians frame shared decision making discussions?
June 28, 2019
